Click here to find out more about Boehringer Ingelheim's BI Cares patient assistance program portal.
US Food and Drug Administration. While these anticoagulants carry similar side effects to warfarin, such as risk for gastrointestinal bleeding and intracranial hemorrhage, INR and PT monitoring are not required. How then are providers to gauge the safety and efficacy of the medication in a patient?
an improvement in patient treatment satisfaction and quality of life and, hopefully, a reduction in healthcare costs … with lower hospitalizations.”The average age of patients in the Hokusai study was 56-57, and just over half were men....